Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 3
1968 2
1981 2
1987 4
1988 7
1989 11
1990 7
1991 7
1992 12
1993 6
1994 9
1995 3
1996 13
1997 10
1998 8
1999 16
2000 11
2001 12
2002 13
2003 9
2004 13
2005 15
2006 12
2007 11
2008 17
2009 19
2010 20
2011 26
2012 17
2013 25
2014 16
2015 18
2016 27
2017 24
2018 34
2019 36
2020 25
2021 38
2022 31
2023 23
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

558 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for italy malavasi
Search for Italo Malavasi instead (2 results)
CD38 antibodies in multiple myeloma: back to the future.
van de Donk NWCJ, Richardson PG, Malavasi F. van de Donk NWCJ, et al. Blood. 2018 Jan 4;131(1):13-29. doi: 10.1182/blood-2017-06-740944. Epub 2017 Nov 8. Blood. 2018. PMID: 29118010 Free article. Review.
Editorial: Immunotherapy in Multiple Myeloma.
Giuliani N, Malavasi F. Giuliani N, et al. Front Immunol. 2019 Aug 14;10:1945. doi: 10.3389/fimmu.2019.01945. eCollection 2019. Front Immunol. 2019. PMID: 31475006 Free PMC article. No abstract available.
A Purinergic Trail for Metastases.
Ferrari D, Malavasi F, Antonioli L. Ferrari D, et al. Trends Pharmacol Sci. 2017 Mar;38(3):277-290. doi: 10.1016/j.tips.2016.11.010. Epub 2016 Dec 16. Trends Pharmacol Sci. 2017. PMID: 27989503 Review.
Cerium Containing Bioactive Glasses: A Review.
Zambon A, Malavasi G, Pallini A, Fraulini F, Lusvardi G. Zambon A, et al. ACS Biomater Sci Eng. 2021 Sep 13;7(9):4388-4401. doi: 10.1021/acsbiomaterials.1c00414. Epub 2021 Sep 1. ACS Biomater Sci Eng. 2021. PMID: 34468119 Free PMC article. Review.
Antibody mimicry, receptors and clinical applications.
Horenstein AL, Chillemi A, Quarona V, Zito A, Mariani V, Faini AC, Morandi F, Schiavoni I, Ausiello CM, Malavasi F. Horenstein AL, et al. Hum Antibodies. 2017;25(3-4):75-85. doi: 10.3233/HAB-160305. Hum Antibodies. 2017. PMID: 28035914 Review.
CD38 as a multifaceted immunotherapeutic target in CLL.
Paulus A, Malavasi F, Chanan-Khan A. Paulus A, et al. Leuk Lymphoma. 2022 Oct;63(10):2265-2275. doi: 10.1080/10428194.2022.2090551. Epub 2022 Aug 17. Leuk Lymphoma. 2022. PMID: 35975791 Review.
CD38 in the age of COVID-19: a medical perspective.
Horenstein AL, Faini AC, Malavasi F. Horenstein AL, et al. Physiol Rev. 2021 Oct 1;101(4):1457-1486. doi: 10.1152/physrev.00046.2020. Epub 2021 Mar 31. Physiol Rev. 2021. PMID: 33787351 Free PMC article. Review.
CD38 and bone marrow microenvironment.
Chillemi A, Zaccarello G, Quarona V, Lazzaretti M, Martella E, Giuliani N, Ferracini R, Pistoia V, Horenstein AL, Malavasi F. Chillemi A, et al. Front Biosci (Landmark Ed). 2014 Jan 1;19(1):152-62. doi: 10.2741/4201. Front Biosci (Landmark Ed). 2014. PMID: 24389178 Free article. Review.
558 results